Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles.

Source:http://linkedlifedata.com/resource/pubmed/id/19604246

Download in:

View as

General Info

PMID
19604246